MitoxantroneLeukemiaLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidLeukemia, ExperimentalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytarabineLeukemia Virus, MurineAntineoplastic AgentsPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Combined Chemotherapy ProtocolsAnthraquinonesLeukemia L1210Leukemia, T-CellDaunorubicinLeukemia, Monocytic, AcuteRemission InductionDrug Resistance, NeoplasmMoloney murine leukemia virusVidarabineNeoplasm ProteinsATP-Binding Cassette TransportersLeukemia, Hairy CellLeukemia, B-CellDrug Resistance, MultiplePrednisoneIdarubicinLeukemia Virus, BovineLeukemia Virus, FelineEtoposideDoxorubicinHL-60 CellsGene Expression Regulation, LeukemicAcute DiseaseLeukemia, Myeloid, Accelerated PhaseLeukemia, Radiation-InducedTumor Cells, CulturedAmsacrineMyeloid-Lymphoid Leukemia ProteinP-GlycoproteinTreatment OutcomeLeukemia P388Leukemia, Biphenotypic, AcuteCyclophosphamideFriend murine leukemia virusRazoxaneBone MarrowDrug EvaluationTopoisomerase InhibitorsVincristineIntercalating AgentsDrug Administration ScheduleLeukemia-Lymphoma, Adult T-CellSurvival AnalysisTopotecanLymphoma, Non-HodgkinDrug Screening Assays, AntitumorLeukemia, Megakaryoblastic, AcuteTaxoidsEstramustineCell SurvivalCell Line, TumorAKR murine leukemia virusFusion Proteins, bcr-ablDisease-Free SurvivalChlorambucilLeukemia, Myeloid, Chronic-PhaseRecurrenceSurvival RateCell LineCardiotoxinsDNA Topoisomerases, Type IIPrecursor B-Cell Lymphoblastic Leukemia-LymphomaDose-Response Relationship, DrugLeukemia, MyeloidApoptosisProstatic NeoplasmsTopoisomerase II InhibitorsAntibiotics, AntineoplasticSalvage TherapyLymphomaPrognosisThioguanineFlow CytometryCyclosporinsDrug ResistanceCladribineBone Marrow TransplantationLeukemia, Plasma CellBase SequenceKaryotyping